KPC PharmaceuticalsInc Crecimiento futuro
Future controles de criterios 4/6
KPC PharmaceuticalsInc is forecast to grow earnings and revenue by 28.4% and 14.2% per annum respectively. EPS is expected to grow by 28.3% per annum. Return on equity is forecast to be 12.3% in 3 years.
Información clave
28.4%
Tasa de crecimiento de los beneficios
28.3%
Tasa de crecimiento del BPA
Crecimiento de los beneficios de Pharmaceuticals | 19.3% |
Tasa de crecimiento de los ingresos | 14.2% |
Rentabilidad financiera futura | 12.3% |
Cobertura de analistas | Good |
Última actualización | 29 Oct 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Is KPC Pharmaceuticals,Inc. (SHSE:600422) Trading At A 42% Discount?
Sep 30These 4 Measures Indicate That KPC PharmaceuticalsInc (SHSE:600422) Is Using Debt Safely
Sep 11KPC PharmaceuticalsInc (SHSE:600422) Will Pay A Larger Dividend Than Last Year At CN¥0.20
Jul 25Investors Still Waiting For A Pull Back In KPC Pharmaceuticals,Inc (SHSE:600422)
Jun 25We Think KPC PharmaceuticalsInc (SHSE:600422) Can Stay On Top Of Its Debt
Jun 04KPC PharmaceuticalsInc's (SHSE:600422) Profits May Not Reveal Underlying Issues
Mar 28Previsiones de crecimiento de beneficios e ingresos
Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
---|---|---|---|---|---|
12/31/2026 | 10,544 | 888 | 168 | 875 | 7 |
12/31/2025 | 9,611 | 738 | 279 | 736 | 8 |
12/31/2024 | 8,352 | 565 | -33 | 766 | 7 |
9/30/2024 | 7,550 | 446 | 557 | 609 | N/A |
6/30/2024 | 7,487 | 451 | 725 | 780 | N/A |
3/31/2024 | 7,646 | 432 | 752 | 811 | N/A |
12/31/2023 | 7,703 | 445 | 291 | 356 | N/A |
9/30/2023 | 7,700 | 397 | 261 | 333 | N/A |
6/30/2023 | 7,825 | 390 | 141 | 222 | N/A |
3/31/2023 | 7,828 | 400 | -51 | 38 | N/A |
12/31/2022 | 8,282 | 383 | 152 | 254 | N/A |
9/30/2022 | 8,419 | 446 | 177 | 296 | N/A |
6/30/2022 | 8,388 | 392 | -23 | 143 | N/A |
3/31/2022 | 8,722 | 427 | -33 | 177 | N/A |
12/31/2021 | 8,254 | 508 | 15 | 252 | N/A |
9/30/2021 | 8,321 | 540 | -136 | 93 | N/A |
6/30/2021 | 8,386 | 564 | -22 | 190 | N/A |
3/31/2021 | 8,045 | 560 | -79 | 118 | N/A |
1/1/2021 | 7,717 | 457 | 251 | 410 | N/A |
9/30/2020 | 7,779 | 445 | 128 | 361 | N/A |
6/30/2020 | 7,788 | 444 | 104 | 393 | N/A |
3/31/2020 | 7,910 | 443 | 292 | 564 | N/A |
12/31/2019 | 8,120 | 454 | 82 | 430 | N/A |
9/30/2019 | 7,817 | 429 | 145 | 452 | N/A |
6/30/2019 | 7,473 | 390 | 131 | 376 | N/A |
3/31/2019 | 7,237 | 356 | 146 | 402 | N/A |
12/31/2018 | 7,102 | 336 | 135 | 352 | N/A |
9/30/2018 | 6,797 | 316 | 362 | 568 | N/A |
6/30/2018 | 6,507 | 295 | N/A | 396 | N/A |
3/31/2018 | 6,280 | 318 | N/A | 197 | N/A |
12/31/2017 | 5,852 | 330 | N/A | 283 | N/A |
9/30/2017 | 5,637 | 357 | N/A | -5 | N/A |
6/30/2017 | 5,330 | 374 | N/A | 165 | N/A |
3/31/2017 | 5,170 | 416 | N/A | 179 | N/A |
12/31/2016 | 5,101 | 407 | N/A | 311 | N/A |
9/30/2016 | 5,161 | 440 | N/A | 326 | N/A |
6/30/2016 | 5,227 | 448 | N/A | 378 | N/A |
3/31/2016 | 5,049 | 433 | N/A | 491 | N/A |
12/31/2015 | 4,916 | 421 | N/A | 477 | N/A |
9/30/2015 | 4,588 | 404 | N/A | 485 | N/A |
6/30/2015 | 4,456 | 367 | N/A | 391 | N/A |
3/31/2015 | 4,361 | 308 | N/A | 447 | N/A |
12/31/2014 | 4,316 | 289 | N/A | 404 | N/A |
9/30/2014 | 4,038 | 264 | N/A | 338 | N/A |
6/30/2014 | 3,860 | 258 | N/A | 467 | N/A |
3/31/2014 | 3,668 | 243 | N/A | 325 | N/A |
12/31/2013 | 3,584 | 232 | N/A | 242 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: 600422's forecast earnings growth (28.4% per year) is above the savings rate (2.9%).
Beneficios vs. Mercado: 600422's earnings (28.4% per year) are forecast to grow faster than the CN market (25.8% per year).
Beneficios de alto crecimiento: 600422's earnings are expected to grow significantly over the next 3 years.
Ingresos vs. Mercado: 600422's revenue (14.2% per year) is forecast to grow faster than the CN market (14% per year).
Ingresos de alto crecimiento: 600422's revenue (14.2% per year) is forecast to grow slower than 20% per year.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: 600422's Return on Equity is forecast to be low in 3 years time (12.3%).